352 related articles for article (PubMed ID: 15115402)
1. Cytotoxic alpha-halogenoacrylic derivatives of distamycin A and congeners.
Beria I; Baraldi PG; Cozzi P; Caldarelli M; Geroni C; Marchini S; Mongelli N; Romagnoli R
J Med Chem; 2004 May; 47(10):2611-23. PubMed ID: 15115402
[TBL] [Abstract][Full Text] [Related]
2. Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione.
Geroni C; Marchini S; Cozzi P; Galliera E; Ragg E; Colombo T; Battaglia R; Howard M; D'Incalci M; Broggini M
Cancer Res; 2002 Apr; 62(8):2332-6. PubMed ID: 11956092
[TBL] [Abstract][Full Text] [Related]
3. The discovery of a new potential anticancer drug: a case history.
Cozzi P
Farmaco; 2003 Mar; 58(3):213-20. PubMed ID: 12620417
[TBL] [Abstract][Full Text] [Related]
4. Brostallicin (PNU-166196), a new minor groove DNA binder: preclinical and clinical activity.
Lorusso D; Mainenti S; Pietragalla A; Ferrandina G; Foco G; Masciullo V; Scambia G
Expert Opin Investig Drugs; 2009 Dec; 18(12):1939-46. PubMed ID: 19938904
[TBL] [Abstract][Full Text] [Related]
5. A new class of cytotoxic DNA minor groove binders: alpha-halogenoacrylic derivatives of pyrrolecarbamoyl oligomers.
Cozzi P
Farmaco; 2001; 56(1-2):57-65. PubMed ID: 11347968
[TBL] [Abstract][Full Text] [Related]
6. Role of glutathione transferases in the mechanism of brostallicin activation.
Pezzola S; Antonini G; Geroni C; Beria I; Colombo M; Broggini M; Marchini S; Mongelli N; Leboffe L; MacArthur R; Mozzi AF; Federici G; Caccuri AM
Biochemistry; 2010 Jan; 49(1):226-35. PubMed ID: 19950984
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of distamycin analogues - new potential anticancer agents.
Drozdowska D; Rusak M; Miltyk W; Midura-Nowaczek K
Arch Pharm (Weinheim); 2009 Feb; 342(2):87-93. PubMed ID: 19173336
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of in vivo antitumor activity of classical anticancer agents by combination with the new, glutathione-interacting DNA minor groove-binder, brostallicin.
Sabatino MA; Colombo T; Geroni C; Marchini S; Broggini M
Clin Cancer Res; 2003 Nov; 9(14):5402-8. PubMed ID: 14614026
[TBL] [Abstract][Full Text] [Related]
9. Brostallicin (PNU-166196)--a new DNA minor groove binder that retains sensitivity in DNA mismatch repair-deficient tumour cells.
Fedier A; Fowst C; Tursi J; Geroni C; Haller U; Marchini S; Fink D
Br J Cancer; 2003 Oct; 89(8):1559-65. PubMed ID: 14562032
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic halogenoacrylic derivatives of distamycin A.
Cozzi P; Beria I; Caldarelli M; Capolongo L; Geroni C; Mongelli N
Bioorg Med Chem Lett; 2000 Jun; 10(11):1269-72. PubMed ID: 10866397
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of hybrid molecules containing alpha-methylene-gamma-butyrolactones and polypyrrole minor groove binders.
Baraldi PG; Del Carmen Nunez M; Tabrizi MA; De Clercq E; Balzarini J; Bermejo J; Estévez F; Romagnoli R
J Med Chem; 2004 May; 47(11):2877-86. PubMed ID: 15139766
[TBL] [Abstract][Full Text] [Related]
12. Recent outcome in the field of distamycin-derived minor groove binders.
Cozzi P
Farmaco; 2000 Mar; 55(3):168-73. PubMed ID: 10919073
[TBL] [Abstract][Full Text] [Related]
13. Distamycin derivatives as potential anticancer agents.
Cozzi P
IDrugs; 2001 May; 4(5):573-81. PubMed ID: 16012903
[TBL] [Abstract][Full Text] [Related]
14. SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 1: cellular pharmacology, in vitro and initial in vivo antitumor activity.
Hartley JA; Spanswick VJ; Brooks N; Clingen PH; McHugh PJ; Hochhauser D; Pedley RB; Kelland LR; Alley MC; Schultz R; Hollingshead MG; Schweikart KM; Tomaszewski JE; Sausville EA; Gregson SJ; Howard PW; Thurston DE
Cancer Res; 2004 Sep; 64(18):6693-9. PubMed ID: 15374986
[TBL] [Abstract][Full Text] [Related]
15. Hybrid molecules between distamycin A and active moieties of antitumor agents.
Baraldi PG; Preti D; Fruttarolo F; Tabrizi MA; Romagnoli R
Bioorg Med Chem; 2007 Jan; 15(1):17-35. PubMed ID: 17081759
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, DNA binding, cytotoxicity and sequence specificity of a series of imidazole-containing analogs of the benzoic acid mustard distamycin derivative tallimustine containing an alkylating group at the C-terminus.
Brooks N; Lee M; Wright SR; Woo S; Centioni S; Hartley JA
Anticancer Drug Des; 1997 Oct; 12(7):591-606. PubMed ID: 9365504
[TBL] [Abstract][Full Text] [Related]
17. DNA sequence-recognizing properties of minor groove alkylating agents. Effects of the replacement of N-methylpyrrole by an N-methylimidazole on tallimustine and its own homologue.
Baraldi PG; Romagnoli R; Spalluto G; Cozzi P; Mongelli N; Bianchi N; Gambari R
Arzneimittelforschung; 2000 Mar; 50(3):309-15. PubMed ID: 10758785
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxics derived from distamycin A and congeners.
Cozzi P; Mongelli N
Curr Pharm Des; 1998 Jun; 4(3):181-201. PubMed ID: 10197039
[TBL] [Abstract][Full Text] [Related]
19. Selective DNA interaction of the novel distamycin derivative FCE 24517.
Broggini M; Erba E; Ponti M; Ballinari D; Geroni C; Spreafico F; D'Incalci M
Cancer Res; 1991 Jan; 51(1):199-204. PubMed ID: 1859575
[TBL] [Abstract][Full Text] [Related]
20. Alpha-bromoacryloyl derivative of distamycin A (PNU 151807): a new non-covalent minor groove DNA binder with antineoplastic activity.
Marchini S; Cirò M; Gallinari F; Geroni C; Cozzi P; D'Incalci M; Broggini M
Br J Cancer; 1999 Jun; 80(7):991-7. PubMed ID: 10362106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]